Taysha Gene Therapies shares owned by Citigroup
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $550k | 311k | 1.77 |
| 2023-09-30 | $888k | 281k | 3.16 |
| 2022-09-30 | $999 | 635 | 1.57 |
| 2021-12-31 | $124k | 11k | 11.69 |
| 2021-03-31 | $12k | 576 | 20.83 |
| 2020-12-31 | $43k | 1.6k | 26.64 |